The New Zealand patient engagement solutions market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The main factors driving the growth would be increasing healthcare expenditure, advancements in technology, and the growing adoption of digital health solutions. The market is segmented by component, delivery mode, application, therapeutic area, functionality and by end-user. Some of the major players are Orion Health, Hills Health Solutions, McKesson, Wolter Kluwer and Siemens Healthineers.
The APAC patient engagement solutions market is a $3.72 Bn market growing at a CAGR of 13.7%. The New Zealand patient engagement solutions market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. In New Zealand, health spending increased to 9.74% of GDP in 2019 from 9.21% in 2018, or $4,037 per person. Healthcare spending as a percentage of GDP in New Zealand normally falls around the OECD average.
New Zealand has a universal healthcare system that provides free or low-cost healthcare to all citizens and permanent residents. In New Zealand, patients have a right to take part in their own care and to information about their health state and available treatments. Patient engagement solutions are tools and techniques used by healthcare practitioners to actively include patients in their care. In New Zealand, there are many options for patient engagement, including telemedicine, mobile health apps, online patient portals, and patient education materials.
Market Growth Drivers
The New Zealand patient engagement solutions market is expected to be driven by factors such as increasing healthcare expenditure, advancements in technology, and the growing adoption of digital health solutions. The government of New Zealand has been an early adopter of digital health solutions, with projects such as the National Telehealth Service and the Electronic Health Record. Solutions for patient engagement, a crucial component of the digital health ecosystem, have benefited from the favourable atmosphere this has produced.
Market Restraints
Limited awareness, insufficient funding and regulatory and privacy considerations are limiting the growth of the patient engagement solutions market in the country. Patient engagement solutions frequently include gathering and using individual health data, which might give rise to legal and privacy issues. The requirement to guarantee that these solutions abide by New Zealand's privacy laws and regulations might make their development and deployment more difficult and expensive.
Key Players
January 2021: Orion and Amneal entered into a strategic partnership. Orion is Amneal's exclusive partner under the collaboration agreement for bringing its portfolio of difficult generic programs to much of Europe, as well as Australia and New Zealand. The initial portfolio will mix generic drugs that are currently on the market in the US with a few high-value pipeline drugs that are currently in development. Beginning in 2023, the first items will be registered in Europe, Australia, and New Zealand.
The Ministry of Health is in charge of establishing and enforcing regulations and standards for healthcare providers, and the government plays a vital role in regulating the healthcare industry. In New Zealand, interest in patient engagement solutions has grown recently, with an emphasis on enabling patients to actively participate in their treatment. The Patient Activation Measure (PAM), which evaluates a patient's capacity to manage their health and healthcare, is one of many initiatives the government has made to promote the adoption of patient engagement solutions. Further, patient engagement solutions must comply with the Health Information Privacy Code and the Health Information Standards in terms of regulatory requirements. These laws guarantee the security of healthcare data and provide patients authority over data usage.
The New Zealand government's healthcare system, which funds healthcare services via the Ministry of Health, determines the reimbursement guidelines for patient engagement solutions. Under specific circumstances and requirements, patient engagement solutions that are deemed to be both medically essential and evidence-based may be eligible for payment. In addition, although the amount of coverage and eligibility requirements may vary from those of the publicly financed healthcare system, private health insurance plans might also cover patient engagement options.
1. Executive Summary
1.1 Service Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Healthcare Services Market in Country
1.6 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Services
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
By component (Revenue, USD Billion):
By Delivery Mode (Revenue, USD Billion):
By Application (Revenue, USD Billion):
By Therapeutic area (Revenue, USD Billion):
By Functionality (Revenue, USD Billion):
By End-user (Revenue, USD Billion):
Methodology for Database Creation
Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.
Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.
How Do We Get It?
Our database is created and maintained through a combination of secondary and primary research methodologies.
1. Secondary Research
With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:
With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:
2. Primary Research
To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:
Combining Secondary and Primary Research
By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:
Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.